Search Results - Asmussen, Jon Thor

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis

    Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis by Bjørnhart, Birgitte, Hansen, Karin Holmskov, Asmussen, Jon Thor, Jørgensen, Trine Lembrecht, Herrstedt, Jørn, Schytte, Tine

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Multiple Myeloma Associated Bone Disease

    Multiple Myeloma Associated Bone Disease by Rasch, Stine, Lund, Thomas, Asmussen, Jon Thor, Lerberg Nielsen, Anne, Faebo Larsen, Rikke, Østerheden Andersen, Mikkel, Abildgaard, Niels

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer

    Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer by Naghavi-Behzad, Mohammad, Oltmann, Hjalte Rasmus, Alamdari, Tural Asgharzadeh, Bülow, Jakob Lykke, Ljungstrøm, Lasse, Braad, Poul-Erik, Asmussen, Jon Thor, Vogsen, Marianne, Kodahl, Annette Raskov, Gerke, Oke, Hildebrandt, Malene Grubbe

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    FDG-PET/CT can rule out malignancy in patients with vocal cord palsy

    FDG-PET/CT can rule out malignancy in patients with vocal cord palsy by Thomassen, Anders, Nielsen, Anne Lerberg, Lauridsen, Jeppe Kiilerich, Blomberg, Björn Alexander, Hess, Søren, Petersen, Henrik, Johansen, Allan, Asmussen, Jon Thor, Sørensen, Jesper Roed, Johansen, Jørgen, Godballe, Christian, Høilund-Carlsen, Poul Flemming

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Benefits and harms of implementing [(18)F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study

    Benefits and harms of implementing [(18)F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study by Vogsen, Marianne, Jensen, Jeanette Dupont, Gerke, Oke, Jylling, Anne Marie Bak, Asmussen, Jon Thor, Christensen, Ivar Yannick, Braad, Poul-Erik, Thye-Rønn, Peter, Søe, Katrine Lydolph, Ewertz, Marianne, Hildebrandt, Malene Grubbe

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT

    Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT by Naghavi-Behzad, Mohammad, Vogsen, Marianne, Vester, Rasmus Mølgård, Olsen, Maiken Madsen Bjerregaard, Oltmann, Hjalte, Braad, Poul-Erik, Asmussen, Jon Thor, Gerke, Oke, Vach, Werner, Kidholm, Kristian, Kodahl, Annette Raskov, Weber, Wolfgang, Hildebrandt, Malene Grubbe

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: